Implantable polymer surfaces exhibiting reduced in vivo inflammatory responses
US12042284B2 · kind B2 · utility
0Cited by
79References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 23, 2018 |
| Grant date | Jul 23, 2024 |
| Priority date | — |
| Expiry date | Sep 19, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2400/18
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Embodiments of the invention provide optimized polymeric surfaces adapted for use with implantable medical devices as well as methods for making and using such polymeric surfaces. These polymer surfaces have a constellation of features that function to inhibit or avoid an inflammatory immune response generated by implantable medical devices. Typical embodiments of the invention include an implantable glucose sensor used in the management of diabetes having a polymer surface with the disclosed constellation of features.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.